Comparator: MK0633

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Asthma

Phase 1

A Study to Evaluate the Safety, Tolerability and Plasma Concentration Profiles of MK0633 in Asthmatic Children Aged 12 to Less Than 16 Years (0633-019)

CompletedNCT00646789

Merck Sharp & Dohme LLCAsthma

Start: 2008-05-31End: 2008-07-31Updated: 2015-06-01

Plasma Levels of MK0633 in Children Ages 6-12 (0633-023)

CompletedNCT00751413

Merck Sharp & Dohme LLCAsthma

Start: 2008-08-31End: 2009-01-31Updated: 2015-06-01